Showing results (51-60 of 112) with videos related to
Sort By:
Pageof 12
Plos One|July 22, 2016
Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern AfricaCarlo Zambonelli, Antu K Dey, Susan Hilt, et al.Nature Medicine|March 4, 2022
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trialLaurence Chu, Keith Vrbicky, David Montefiori, et al.Journal of Medicinal Chemistry|July 8, 2005
Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymeraseSteven Harper, Salvatore Avolio, Barbara Pacini, et al.Biorxiv : the Preprint Server for Biology|January 27, 2021
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variantsKai Wu, Anne P Werner, Juan I Moliva, et al.The Journal of Biological Chemistry|May 12, 2007
Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulationTimothy S Fisher, Paola Lo Surdo, Shilpa Pandit, et al.NPJ Vaccines|April 20, 2023
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infectionBrooke Bollman, Naveen Nunna, Kapil Bahl, et al.Vaccine|August 21, 2025
Design and preclinical assessment of mRNA-1345 prefusion F glycoprotein-encoding mRNA vaccine for respiratory syncytial virusChristine A Shaw, Guillaume B E Stewart-Jones, Patricia Jorquera, et al.Immunity|January 29, 2022
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernPaulina Kaplonek, Stephanie Fischinger, Deniz Cizmeci, et al.Nature Medicine|September 16, 2021
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysisAngela Choi, Matthew Koch, Kai Wu, et al.The Journal of Infectious Diseases|February 7, 2024
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 VaccineXintao Hu, Krithika P Karthigeyan, Savannah Herbek, et al.Pageof 12